Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaDocumentPhase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS LymphomaAjouté par Shiro0 évaluation0% ont trouvé ce document utileEnregistrer Phase 1b Trial of An Ibrutinib-Based Combination Therapy in Recurrent/refractory CNS Lymphoma pour plus tard